CAR T-Cell Therapy Market Size, Share, Growth Analysis, By Product (Yescarta, Kymriah), By Target (CD19, BCMA), By Indication, By Demographic, By End User, By Region - Industry Forecast 2024-2031

Global CAR T-Cell Therapy Market size was valued at USD 5.2 billion in 2022 and is poised to grow from USD 7.27 billion in 2023 to USD 106.06 billion by 2031, growing at a CAGR of 39.80% during the forecast period (2024-2031).

Rising incidence of cancer around the world is projected to primarily augment the demand for CAR T-cell therapy (CAR-T (Chimeric Antigen Receptor T-cell) therapy) over the coming years. Rising investments in cell research and advancements in genetic engineering and editing technologies are also expected to play a crucial role in CAR T-cell therapy market development over the coming years. High demand for personalized medicine is also estimated to uplift the demand for CAR T-cell therapy across the forecast period and beyond. Growing use of CAR T-cell therapy to treat blood cancer indications is also expected to create new opportunities for CAR T-cell therapy providers in the future. Increasing number of approvals for novel CAR T-cell therapy for the treatment of various chronic indications that are rising in incidence on a global level. On the contrary, high costs of treatment, concerns regarding safety of the procedure and side effects, and limited availability are estimated to be key restraints for CAR T-cell therapy market over the coming years.